Osiris Therapeutics (OSIR) Cash Flow Statement

Click line-items for a historical chart and %

Net income
Depreciation and amortization	850K
Non cash share-based payments	2.38M
Non cash expense-extension of expiration date warrant to related party
Changes in operating assets and liabilities:
Accounts and other receivables	-14.77M
Prepaid expenses, inventory, and other current assets	-517K
Other assets
Accounts payable and accrued expenses
Deferred revenue
Net cash used in continuing operations	-9.25M
Changes in operating assets and liabilities:
Accounts payable and accrued expenses	0
Net cash used in discontinued operations	0
Net cash used in operating activities	-9.25M
Purchases of property and equipment	-943K
Proceeds from sale of investments available for sale	142.44M
Purchases of investments available for sale	-129.98M
Net cash provided by investing activities	22.23M
Principal payments on capital lease obligations	-34K
Proceeds from the exercise of stock options	1.06M
Net cash provided by (used in) financing activities
Net increase in cash	13.59M
Cash at beginning of period	2.21M
Cash at end of period	15.8M

Entities mentioned with OSIR

View All Entities